An Observational Study Evaluating Therapy Optimisation Using High-frequency and High-dosage Administration of Interferon-beta (Rebif®) in Multiple Sclerosis (MS) Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
This was an observational, single arm, multicentric study conducted for the adjustment of treatment strategy and its monitoring using high-frequency and high-dosage administration of interferon-beta (Rebif) in MS subjects. Study focussed on assessment of the effectiveness and safety of existing immunomodulatory basis therapy in MS subjects.
Epistemonikos ID: 0eabc6028bc9740579812064424e92ca2f2e1efe
First added on: May 05, 2024